Company news
Odyssey Therapeutics, Inc. (NASDAQ:ODTX) news
Odyssey Therapeutics, Inc. news releases on 6ix. Latest, Oct 6, 2026: Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data…
Press releases & updates
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
October 5, 2026
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
October 6, 2026
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
September 16, 2026
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
August 26, 2026
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 4, 2026
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
June 17, 2026
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
May 6, 2026